Wednesday, November 17, 2010

Google Alert - health

News9 new results for health
 
FDA sends warning letters to makers of caffeinated alcohol drinks
Los Angeles Times
By Mary Forgione, Los Angeles Times Caffeinated alcoholic beverage manufacturers received official word Wednesday from the Food and Drug Administration that caffeine added to their products is considered an "unsafe food additive. ...
See all stories on this topic »

Los Angeles Times
Kidney surgery reduces high blood pressure, study finds
Los Angeles Times
A simple procedure that destroys certain nerves in the organ can help patients whose condition hasn't responded to conventional medications. By Thomas H. Maugh II, Los Angeles Times A simple surgical procedure destroying certain nerves in the kidney ...
See all stories on this topic »
FDA advisory panel approves new drug for lupus, Benlysta
Los Angeles Times
By Thomas H. Maugh II, Los Angeles Times A Food and Drug Administration advisory panel Tuesday voted 13-2 to recommend approval of Benlysta, the first new drug to treat lupus in more than half a century. The FDA has set Dec. ...
See all stories on this topic »
Florida woman diagnosed with cholera
CNN
By the CNN Wire Staff A Haitian Ministry of Health worker hands out an informational pamphlet about cholera in Port-au-Prince. (CNN) -- A woman who recently returned to Florida from Haiti has been diagnosed with cholera, the Florida Department of ...
See all stories on this topic »
Republicans grill Obama's Medicare-Medicaid chief
Los Angeles Times
Dr. Donald Berwick, appointed during a congressional recess, says repeal of the healthcare law would rob seniors of the ability to afford 'life-saving medicine.' Meanwhile, GOP senators zero in on the method of Berwick's appointment. By Noam N. Levey, ...
See all stories on this topic »
Merck Cholesterol Drug Looks Promising
New York Times
By NATASHA SINGER Merck has a potential blockbuster in anacetrapib, an experimental cholesterol drug that increases HDL, or "good" cholesterol even as it lowers LDL, the "bad" cholesterol. The drug could potentially have sales of more than $1 billion a ...
See all stories on this topic »
US panel backs Dendreon's Provenge for Medicare
Reuters
By Susan Heavey WASHINGTON (Reuters) - A US advisory panel backed Dendreon Corp's Provenge prostate cancer therapy on Wednesday, telling the Medicare insurance program for the elderly that available data showed it could help patients. ...
See all stories on this topic »
Post-traumatic stress ups heart disease risk in vets
Reuters
CHICAGO (Reuters) - US military veterans who have post-traumatic stress disorder -- a condition marked by severe anxiety, sleep disruptions, hyperarousal and impaired concentration -- have double the risk of dying and a greater risk of developing ...
See all stories on this topic »
Still Too Many Preterm Births in U.S.: Report
BusinessWeek
By Jenifer Goodwin and Alan Mozes WEDNESDAY, Nov. 17 (HealthDay News) -- Forty states and the District of Columbia made progress in reducing their rate of premature births, but the improvements were too small to raise the overall US score from a ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Remove this alert.
Create another alert.
Manage your alerts.

No comments:

Post a Comment